Repeat Expansions in Are a Cause of Spinocerebellar Ataxia Type 36 in the British Population
Overview
Authors
Affiliations
Spinocerebellar ataxias form a clinically and genetically heterogeneous group of neurodegenerative disorders characterized by progressive cerebellar ataxia. Their prevalence varies among populations and ethnicities. Spinocerebellar ataxia 36 is caused by a GGCCTG repeat expansion in the first intron of the gene and is characterized by late-onset ataxia, sensorineural hearing loss and upper and lower motor neuron signs, including tongue fasciculations. Spinocerebellar ataxia 36 has been described mainly in East Asian and Western European patients and was thought to be absent in the British population. Leveraging novel bioinformatic tools to detect repeat expansions from whole-genome sequencing, we analyse the repeat in 1257 British patients with hereditary ataxia and in 7506 unrelated controls. We identify pathogenic repeat expansions in five families (seven patients), representing the first cohort of White British descent patients with spinocerebellar ataxia 36. Employing approaches using whole-genome sequencing data, we found an 87 kb shared haplotype in among the affected individuals from five families around the repeat region, although this block was also shared between several controls, suggesting that the repeat arises on a permissive haplotype. Clinically, the patients presented with slowly progressive cerebellar ataxia with a low rate of hearing loss and variable rates of motor neuron impairment. Our findings show that the expansion causes ataxia in the British population and that spinocerebellar ataxia 36 can be suspected in patients with a late-onset, slowly progressive ataxia, even without the findings of hearing loss and tongue fasciculation.
Another common genetic ataxia in South Korea: Spinocerebellar ataxia 36.
Ahn J, Lee S, Moon J, Han Y, Chang H, Youn J Eur J Hum Genet. 2025; .
PMID: 39994402 DOI: 10.1038/s41431-024-01783-9.
Analysis-ready VCF at Biobank scale using Zarr.
Czech E, Millar T, Tyler W, White T, Elsworth B, Guez J bioRxiv. 2024; .
PMID: 38915693 PMC: 11195102. DOI: 10.1101/2024.06.11.598241.